Intragastrischer ballon zur gewichtsreduktion: Ergebnisse bei 100patienten nach 2,5 Jahren

BACKGROUND AND STUDY AIMS: To determine long-term outcome after treatment with an intra-gastric balloon for 6 months, with no structured weight maintenance program offered after balloon removal. PATIENTS AND METHODS: 100 consecutive overweight / obese individuals (mean body mass index [BMI] 35.0 ± 5.6 kg / m 2 ) were prospectively fol-lowed after endoscopic implantation of a saline filled intragastric balloon; 97 completed final -follow-up at a mean of 4.8 ± 1.6 years. Success-ful intragastric balloon therapy was defined as weight loss at 6 months of ≥ 10 % of weight at -baseline, that remained ≥ 10 % until 2.5 years, with-out bariatric surgery. All analyses followed intention-to-treat principles. RESULTS: At 6 months, mean weight loss was 12.6 ± 8.3 kg, 63 individuals had ≥ 10 % baseline weight loss; no severe morbidity was detected. During the first and second years following intragastric balloon removal, mean body mass in-creased by 4.2 ± 6.8 and 2.3 ± 6.0 kg, respectively (P < 0.001 for both year-on-year comparisons). At 2.5 years, intragastric balloon therapy had been successful in 24 participants. At final follow-up (4.8 ± 1.6 years), 28 had ≥ 10 % baseline weight loss, 35 had undergone bariatric surgery (60 % had preoperative mass higher than baseline), and 3 were lost to follow-up; the 34 remaining had lost 1.5 ± 5.8 kg compared with baseline. During follow-up, 13 had a second intragastric balloon implanted and 13 took sibutramine for short -periods. CONCLUSION: Intragastric balloon therapy was relatively innocuous and associated with successful weight loss and maintenance at 2.5 years in a quarter of participants. It represents a valid op-tion for weight loss.